These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 399843)

  • 21. [The morphological diagnosis of malignant non-Hodgkin's lymphomas (lymphosarcomas)].
    Probatova NA
    Arkh Patol; 1990; 52(9):72-5. PubMed ID: 2270988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata.
    Brouet JC; Labaume S; Seligmann M
    Br J Cancer Suppl; 1975 Mar; 2():121-7. PubMed ID: 1081001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
    Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
    Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histologic classification and immunophenotyping of canine non-Hodgkin's lymphomas: unexpected high frequency of T cell lymphomas with B cell morphology.
    Teske E; Wisman P; Moore PF; van Heerde P
    Exp Hematol; 1994 Nov; 22(12):1179-87. PubMed ID: 7925781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The results of histological and immunohistological studies of primary biopsies in 400 patients with non-Hodgkin's lymphoma in the North-West region of Russia (according to WHO classification)].
    Krivolapov IuA
    Ter Arkh; 2004; 76(7):64-70. PubMed ID: 15379131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.
    Drillenburg P; van der Voort R; Koopman G; Dragosics B; van Krieken JH; Kluin P; Meenan J; Lazarovits AI; Radaszkiewicz T; Pals ST
    Am J Pathol; 1997 Mar; 150(3):919-27. PubMed ID: 9060830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
    Nguyen PL; Harris NL; Ritz J; Robertson MJ
    Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-Hodgkin's lymphoma in children.
    Pinkel D; Johnson W; Aur RJ
    Br J Cancer Suppl; 1975 Mar; 2():298-323. PubMed ID: 1101924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
    Schmidt U; Herbst J; Metz KA; Leder LD
    J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-Hodgkin's lymphomas. analysis of 109 Japanese cases with the use of LSGJ classification.
    Shimizu M; Miura M; Kitahara M; Katayama I
    Am J Pathol; 1982 Jan; 106(1):30-9. PubMed ID: 7034544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Classiciation of non-Hodgkin's lymphomas of childhood (author's transl)].
    Lennert K
    Klin Padiatr; 1977 Jan; 189(8):7-13. PubMed ID: 320375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of local control in patients with non-Hodgkin's lymphoma according to the WHO classification.
    Sakata K; Satoh M; Someya M; Nagakura H; Oouchi A; Nakata K; Kogawa K; Koito K; Hareyama M; Himi T
    Strahlenther Onkol; 2005 Jun; 181(6):385-91. PubMed ID: 15925981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pattern of malignant lymphomas in Rwanda.
    Ngendahayo P; Schmauz R
    Bull Cancer; 1992; 79(11):1087-96. PubMed ID: 1302535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biology and differentiation of lymphocytes in the classification of lymphomas].
    Mariuzzi G; Di Loreto C; Mariuzzi L
    Recenti Prog Med; 1990 Oct; 81(10):621-8. PubMed ID: 2291005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
    Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
    Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas.
    Piccaluga PP; Califano A; Klein U; Agostinelli C; Bellosillo B; Gimeno E; Serrano S; Solè F; Zang Y; Falini B; Zinzani PL; Pileri SA
    Haematologica; 2008 Jul; 93(7):1033-8. PubMed ID: 18492688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunologic approach to the pathology of malignant lymphomas.
    Lukes RJ
    Am J Clin Pathol; 1979 Oct; 72(4 Suppl):657-69. PubMed ID: 386777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A study of non-Hodgkin's lymphoma (author's transl)].
    Kotoo Y
    Fukuoka Igaku Zasshi; 1978 Feb; 69(2):73-82. PubMed ID: 306366
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.